📌 Key Points
- Sudipto Sen criticized ‘The Kerala Story 2’ for relying on WhatsApp forwards.
- Vipul Amrutlal Shah refuted Sen’s claims, calling his script ‘trash’.
- Shah defended his film’s research, stating Sen wasn’t involved in the entire process.
- ‘The Kerala Story 2’ opened to mixed reviews and has collected ₹ 20.15 crore so far.
Vipul Amrutlal Shah, the producer of ‘The Kerala Story 2,’ has strongly criticized Sudipto Sen’s remarks about the film’s research. Sen claimed the film relied on WhatsApp forwards, which Shah refuted, calling his script ‘trash’.
Sen’s Criticism Sparks Controversy
Recently, Sudipto Sen , director of The Kerala Story , criticised the sequel’s research and claimed that the film was based on WhatsApp forwards. While the director later clarified that his remarks had been misconstrued, Vipul Amrutlal Shah , producer of The Kerala Story 2, has reacted strongly to Sen’s criticism.
Vipul added, “He doesn’t even know what research we have done. He was not part of the entire research process, so how can he make those comments? I don’t usually comment, but when somebody attacks my film, that is when I am compelled to react. Otherwise, I don’t like to react. The film has been released, and I know the statements he made are baseless. That’s all I can say.”
Shah Defends Film’s Research
However, the director later said that his statement had been misconstrued and claimed that he turned down the film because his research was limited to one region.
However, a bench of Justices S. A. Dharmadhikari and P. V. Balakrishnan lifted the stay, allowing the film to release in theatres as planned.
‘Kerala Story 2’ Box Office Performance
A sequel to the 2023 film The Kerala Story, the film stars Ulka Gupta, Aditi Bhatia and Aishwarya Ojha in the lead roles.
The film opened to mixed reviews from audiences and has so far collected only ₹ 20.15 crore at the domestic box office. It is lagging behind its first part, which collected ₹ 302 crore worldwide.
The controversy surrounding ‘The Kerala Story 2’ continues as the film faces criticism and defends its research. Despite mixed reviews, the film’s box office performance is being closely watched.
